Standout Papers

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic ast... 2001 2026 2009 2017 637
  1. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics (2001)
    M. Solèr, Jonathan Matz et al. European Respiratory Journal

Immediate Impact

4 from Science/Nature 81 standout
Sub-graph 1 of 18

Citing Papers

Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
2024 Standout
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
2021 Standout
2 intermediate papers

Works of J. Thirlwell being referenced

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
2001 Standout
Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen–induced seasonal allergic rhinitis
2000
and 1 more

Author Peers

Author Last Decade Papers Cites
J. Thirlwell 1239 1697 1015 16 1.9k
Niroo Gupta 1694 2474 1430 17 2.8k
F. E. Hargreave 1852 2053 423 27 2.5k
Sofia Mosesova 1441 2125 571 10 2.5k
Geoffrey Gilmartin 1861 2048 432 18 2.8k
Merdad V. Parsey 831 1161 283 15 1.7k
Karl Yen 2107 576 304 21 2.8k
Charlene M. Prazma 1075 1430 312 25 1.8k
Steven F. Weinstein 1533 2270 995 44 2.6k
S. Hedgecock 1064 1548 1055 15 1.8k
Guiquan Jia 1340 1631 306 15 2.3k

All Works

Loading papers...

Rankless by CCL
2026